Readily secured an $11 million Series A to build a compliance intelligence platform, according to the funding announcement. The round was led by Define Ventures with participation from Y Combinator and the California Health Care Foundation Innovation Fund. While the provided summary does not detail specific product modules, the investment highlights sustained appetite for regulatory- and operations-focused infrastructure that can reduce cost and risk in healthcare organizations. In a market where evidence generation, documentation, and payer/regulatory interactions are increasingly data-dependent, compliance tooling is becoming a core enabling layer. For biotech and life sciences operators, the practical takeaway is that compliance automation and intelligence vendors are moving from pilot-friendly offerings toward scalable platforms that could integrate across workflows and support audit readiness.